about
T Cell Migration in Rheumatoid ArthritisPlasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritisStructural Evaluation and Binding Mode Analysis of CCL19 and CCR7 Proteins-Identification of Novel Leads for Rheumatic and Autoimmune Diseases: An Insilico study.IL-6 in diabetes and cardiovascular complications.Protective effect of Asarum extract in rats with adjuvant arthritis.Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.Deletion of IFT20 in early stage T lymphocyte differentiation inhibits the development of collagen-induced arthritis.Chemically Modified Interleukin-6 Aptamer Inhibits Development of Collagen-Induced Arthritis in Cynomolgus Monkeys.Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cellsAttenuation of Collagen-Induced Arthritis in rat by nicotinic alpha7 receptor partial agonist GTS-21.Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis.CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis.Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis.IL-6 blockade in chronic inflammatory diseases.Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review.Selected cytokine pathways in rheumatoid arthritis.Phytoconstituents as pharmacotherapeutics in rheumatoid arthritis: challenges and scope of nano/submicromedicine in its effective delivery.Establishment of an in vitro three-dimensional model for cartilage damage in rheumatoid arthritis.AMPK Activation by A-769662 Controls IL-6 Expression in Inflammatory Arthritis.Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designsA role for syntaxin 3 in the secretion of IL-6 from dendritic cells following activation of toll-like receptors.The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.Astilbin from Smilax glabra Roxb. Attenuates Inflammatory Responses in Complete Freund's Adjuvant-Induced Arthritis Rats.T cell subsets: an integral component in pathogenesis of rheumatic heart disease.Taming the Flames: Targeting White Adipose Tissue Browning in Hypermetabolic Conditions.A review of sarilumab for the treatment of rheumatoid arthritis.The in vitro and in vivo anti-inflammatory activities of alphitonin-4-O-β-D-glucopyranoside.Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cellsSaquinavir-NO Inhibits IL-6 Production in Macrophages
P2860
Q26797338-5FD48591-E648-4208-BB86-4470607D02A0Q28538381-C86D2CF2-DA7A-41AC-A702-456317FA6FEFQ30399603-4B8FD156-E686-4B5F-9F6E-1DADD5E67CB7Q34025142-D89F7D38-C38C-4C6F-B4A3-AEAF780A0C5CQ34292214-763E24F1-D087-4478-BD96-E1F9DA8992D7Q35540927-C859FEB8-AEA5-47D3-93ED-2741D600CE48Q35751522-12BBE348-C883-4A46-8981-06609B304703Q36579912-1244756A-CE84-4C6F-AFE6-606B5148038EQ37625953-96575AFB-01CE-4646-8947-661ACC8B5568Q37639837-4A412BAE-855C-4E25-A319-642D9DEC198FQ38155126-8BCB5DFE-805A-4257-8FA4-A92355E26551Q38176229-816382B7-4EB8-4996-98CC-E16F8B576EB8Q38203622-A438A341-3B00-4FF3-929E-0D7989793854Q38261783-C8B398C6-D5CA-4370-B8E3-2A92A9E8B776Q38263540-5B601225-58A3-457A-AA67-58C7B2D03C05Q38755912-B27EA7F2-9241-4542-B92C-277E4E0B0AEDQ38989167-8901DDFE-289B-4DD0-A71F-D9F36C69E83FQ39024735-D7619D71-E99B-4400-A14D-EE9FBE50055FQ40423409-B789F1E4-B787-489E-9138-87B16E777EF2Q41450339-5CD966F4-38B3-427D-AB4D-924F608D161EQ42119244-8087AD32-A937-4249-842B-1F8158A1A27BQ42468643-52660246-31B9-4629-8591-1FF2129C98F3Q43409157-6D5D2262-42A6-4DA3-BD74-53105C13F8DAQ47369105-0C38BF66-9CDB-44C7-BE4C-7EBB7E979A99Q49921559-B638FE18-D24F-4880-AABD-7F5C05F036D6Q50086851-D4EBF458-6626-4A37-9359-E9B10F7B09B7Q50123729-7505A956-53BF-49C8-A713-FFD4A5A141F2Q58291513-5678ACCB-A725-4E52-9F3C-08ED3E8F9754Q59089968-D3525394-AB77-4D78-8779-65DA0210A7C0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting interleukin-6 in rheumatoid arthritis.
@en
Targeting interleukin-6 in rheumatoid arthritis.
@en-gb
type
label
Targeting interleukin-6 in rheumatoid arthritis.
@en
Targeting interleukin-6 in rheumatoid arthritis.
@en-gb
prefLabel
Targeting interleukin-6 in rheumatoid arthritis.
@en
Targeting interleukin-6 in rheumatoid arthritis.
@en-gb
P2860
P1154
2-s2.0-84878843826
P1433
P1476
Targeting interleukin-6 in rheumatoid arthritis.
@en
P2093
Md Yuzaiful Md Yusof
P2860
P2888
P304
P356
10.1007/S40265-013-0018-2
P50
P5530
P577
2013-03-01T00:00:00Z
P5875
P6179
1008400750